SBIR/STTR Research Award
Leveraging Roundtrip, the single touchpoint for medical transportation, to eliminate transportation as a barrier to care for specialized patient populations such as those with opioid use disorder.
Award amount
$252,131Program and phase
SBIR · Phase IAward year
2020Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- RIDE ROUNDTRIP INC
- Proposal award date
- 2020-04-01
- Contract end date
- 2021-03-31
- UEI
- VL8MNAK19KW6
- Solicitation number
- DA19-019
- Topic code
- NIDA
Research abstract
ABSTRACT
Roundtrip’s transportation software platform is a turnkey solution that addresses transportation as a social
determinant of health by offering a single touchpoint for any healthcare organization to coordinate all levels of
non-emergency transportation (rideshare, medical sedan, wheelchair van, non-emergency ambulance) for
specialized patient populations. Given the increasingly strong correlation between transportation, lack of
healthcare access, and patient no-shows to medical care, this project aims to study the effect of providing
subsidized rides for patients afflicted by opioid use disorder (OUD) or drug use that screen positive for a
transportation need. Roundtrip is focused on removing transportation as a barrier to access care, especially
as it pertains to substance and drug use. Roundtrip is currently partnered with some of the most reputed
national healthcare brands in the US across 20 states, including Geisinger, Johns Hopkins, the NIH, and
large behavioral health systems like Aurora Behavioral, moving patients daily that need various forms of
medical care including drug addiction and associated behavioral health issues related to opioid use. This
project seeks to measure the impact of access to timely transportation on overall clinical outcomes for the
aforementioned group of pre-identified patients, allowing partnered healthcare providers to effectively
administer medical care and prescribe medication-assisted treatment to those in need. We will determine if
the Roundtrip platform is an appropriate, scalable mechanism to promote an increased adoption of drug
treatment programs that have had well-documented success in reducing overall drug use by alleviating the
burden of transportation and the associated logistical challenges of such programs. Thus, we look to create a
scalable and data-driven mechanism that expands access to medical care for those affected by OUD and/or
drug use, with the goal of demonstrating a viable and replicable model that can be applied in communities
across the country.PROJECT NARRATIVE
3.6 million medical appointments every year are missed or delayed primarily due to a transportation barrier –
contributing to a staggering $150 billion-dollar burden on the U.S. healthcare system – and missed
appointments not only put patients at risk for Emergency Department (ED) visits and worsened health
outcomes, but also have cascading downstream effects on caregivers, providers, insurers, and taxpayers
that bear the operational and financial burden. Health care systems, in particular, lose large portions of
overall revenue from missed appointments due to the lack of reimbursement opportunities and misalignment
of operational resources. With lack of access to transportation being a significant reason for missed
appointments and inconsistent adherence to medical treatment, this project seeks to the showcase the
positive impact that a digital transportation coordination platform, such as Roundtrip, can have in effectively
connecting OUD and drug use patients with timely medical care.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)